These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8667225)

  • 21. Positive inotropic effect of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1 -piperazinyl]-2(1H)-quinolinone (OPC-8212) and mechanism of action in guinea pig ventricular myocardium.
    Takeya K; Yajima M; Kobayashi-Ando S; Ando H
    Arzneimittelforschung; 1984; 34(3A):364-70. PubMed ID: 6331466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological characterization of effects of UK-1745, a novel cardiotonic agent with beta-adrenoceptor-blocking action, in aequorin-loaded canine right ventricular muscle.
    Sawada H; Endoh M
    J Mol Cell Cardiol; 1999 May; 31(5):1047-62. PubMed ID: 10336843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel inotropic agent CGP 48506 alters force primarily by Ca(2+)-independent mechanisms in porcine skinned trabeculae.
    Palmer S; Di Bello S; Davenport SL; Herzig JW
    Cardiovasc Res; 1996 Aug; 32(2):411-21. PubMed ID: 8796129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ca2+ channel activation by CGP 48506, a new positive inotropic benzodiazocine derivative.
    Herzig S
    Eur J Pharmacol; 1996 Jan; 295(1):113-7. PubMed ID: 8925868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-Methyl-6-phenyl-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazocine-2,4-dione (BA 41899): representative of a novel class of purely calcium-sensitizing agents.
    Herold P; Herzig JW; Wenk P; Leutert T; Zbinden P; Fuhrer W; Stutz S; Schenker K; Meier M; Rihs G
    J Med Chem; 1995 Jul; 38(15):2946-54. PubMed ID: 7636855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of a new positive inotropic agent, 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212), on thin bundles of skinned fibers from cardiac muscle.
    Endo M
    Arzneimittelforschung; 1984; 34(3A):380-3. PubMed ID: 6540092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the cardiac contractile, biochemical and electrophysiological effects of cantharidin, a phosphatase inhibitor.
    Neumann J; Herzig S; Boknik P; Apel M; Kaspareit G; Schmitz W; Scholz H; Tepel M; Zimmermann N
    J Pharmacol Exp Ther; 1995 Jul; 274(1):530-9. PubMed ID: 7616441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of the contractile effects of flosequinoxan.
    Zimmermann N; Bodor GS; Boknik P; Gams E; Jones LR; Neumann J; Scholz H
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):385-90. PubMed ID: 7630429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cardiac effects of Cordemcura in vitro].
    Hagen A; Sonnenburg F; Frömmel B; Fischer R; Hennig R; Just E; Landmann H; Göres E
    Pharmazie; 1986 Mar; 41(3):186-9. PubMed ID: 3714791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular mechanisms responsible for the inotropic action of insulin on failing human myocardium.
    Hsu CH; Wei J; Chen YC; Yang SP; Tsai CS; Lin CI
    J Heart Lung Transplant; 2006 Sep; 25(9):1126-34. PubMed ID: 16962476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation into the inotropic mechanisms of sulmazole.
    Walland A
    Arzneimittelforschung; 1985; 35(1A):369-76. PubMed ID: 4039176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphodiesterase inhibition by naloxone augments the inotropic actions of beta-adrenergic stimulation.
    Park WK; Chang CH; Chae JE; Kim MH; Cho YL; Ahn DS
    Acta Anaesthesiol Scand; 2009 Sep; 53(8):1043-51. PubMed ID: 19572940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel cardiotonic agent SCH00013 acts as a Ca++ sensitizer with no chronotropic activity in mammalian cardiac muscle.
    Sugawara H; Endoh M
    J Pharmacol Exp Ther; 1998 Oct; 287(1):214-22. PubMed ID: 9765340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of phosphodiesterase inhibition and of carbachol on inotropic effects of 8-substituted cyclic AMP analogues.
    Korth M; Engels J; Schäfer-Korting M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):166-75. PubMed ID: 2436059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological profile of LAS 31180, a new inotropic/vasodilator quinolone derivative.
    Gras J; Cardelús I; Beleta J; Gristwood RW; Palacios JM; Llenas J
    Arzneimittelforschung; 2000 Nov; 50(11):980-6. PubMed ID: 11148864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of a new Ca(2+) sensitizer.
    Dorigo P; Floreani M; Santostasi G; Maragno I; Danieli-Betto D; Germinario E; Magno SM; Primofiore G; Marini AM; Da Settimo F
    J Pharmacol Exp Ther; 2000 Dec; 295(3):994-1004. PubMed ID: 11082434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The positive inotropic activity of 5-bromoisatin (5-bromo-indoline-2,3-dione)].
    Garalene V
    Eksp Klin Farmakol; 1999; 62(3):20-4. PubMed ID: 10439942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of oxyphenamone, a new inodilator, on isolated cardiac muscles and arteries].
    Fan LL; Sun LH; Lin Y
    Yao Xue Xue Bao; 1997 Nov; 32(11):808-12. PubMed ID: 11596198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytes.
    Kajimoto K; Hagiwara N; Kasanuki H; Hosoda S
    Br J Pharmacol; 1997 Aug; 121(8):1549-56. PubMed ID: 9283687
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of emodin on the intracellular calcium concentration ([Ca2+]i) and L-type calcium current of the single ventricular mytocytes from guinea pig].
    Liu Y; Shan HL; Sun HL; He SZ; Yang BF
    Yao Xue Xue Bao; 2004 Jan; 39(1):5-8. PubMed ID: 15127572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.